Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, ...

Appraisal of Dupilumab for treating moderate to severe chronic obstructive pulmonary disease [ID6235] 6.1. Introduction by the Chair, Radha Todd - Part 1 only (open session) 6.2. Declaration of ...

A new study highlights the risks of atopic dermatitis flare-ups after discontinuing dupilumab and the likelihood of ...